Behavioral Health

Postpartum anxiety: More common than you think

Author and Disclosure Information

 

References

SCREENING FOR POSTPARTUM ANXIETY

Screening for perinatal depression has become standard of care, and the Edinburgh Postnatal Depression Scale (EPDS) is a widely used instrument.1 The EPDS, a 10-question self-report scale, was created and validated to screen for perinatal depression, with a cutoff of > 10/30 usually considered a positive result.

Researchers have investigated the utility of the EPDS as a screening tool for perinatal anxiety as well.21-23 These studies show some promise, but there are questions as to whether a total score or a subscale score of the EPDS is most accurate in detecting anxiety. Women with perinatal anxiety may score low on the total EPDS, yet score higher on 3 anxiety-specific questions (TABLE 123). For this reason, several studies propose an EPDS anxiety subscore or subscale (referred to as EPDS-3A).

EPDS-3A subscale: Questions 3-5 from the Edinburgh Postnatal Depression Scale

Of note, there are some women who will score high on the subscale who do not ultimately meet the criteria for an anxiety disorder diagnosis. Clinicians should not over-interpret these scores and should always use sound clinical judgment when making a diagnosis.

Research has also focused on using the GAD 7-item (GAD-7) scale (TABLE 224),25 and on the development of new tools and screening tools designed specifically for perinatal anxiety, including the Postpartum Worry Scale26 and the Postpartum Specific Anxiety Scale (PSAS).27

Generalized Anxiety Disorder 7-item (GAD-7) scale

Family physicians may consider using the EPDS subscale if they are already using the EPDS, or adding the GAD-7 as a separate screening instrument during a postpartum visit. To date there is no one standard recommendation or screening tool.

Continue to: NONPHARMACOLOGIC TREATMENT

Pages

Recommended Reading

‘Difficult’ discussions reduced anxiety, depression in life-limiting cancer patients
MDedge Family Medicine
Cannabis use, potency linked to psychotic disorder risk
MDedge Family Medicine
FDA approves brexanolone for postpartum depression
MDedge Family Medicine
Amphetamine tied to higher risk of new-onset psychosis than methylphenidate
MDedge Family Medicine
Depression: a changing concept in the age of ketamine
MDedge Family Medicine
Patients with OCD/hoarding differ from those with OCD/nonhoarding
MDedge Family Medicine
BP control slowed brain damage in elderly hypertensives
MDedge Family Medicine
Report calls for focus on ‘subpopulations’ to fight opioid epidemic
MDedge Family Medicine
Scales assessing pediatric OCD possess little symptom overlap
MDedge Family Medicine
Poor oral health predicts children’s school problems
MDedge Family Medicine